US Module

This study is based on a sample of 1,711 U.S. BSL CLO deals. Deals that were called before May 2025, along with static deals, are excluded from the analysis.

This study is based on a sample of 1,712 U.S. BSL CLO deals. Diameter, OHA, and GoldenTree have delivered solid equity performance. In terms of AUM and performance, managers with over USD 10 billion in AUM outperformed their peers. For example, larger managers recorded a median performance percentile of 56th, compared with 43rd for mid-sized managers and 40th for those with smaller CLO platforms.

A large minority CLO equity note was on a BWIC yesterday, and the tranche traded well. The deal, originally priced with a closing date of 28 June 2023, recently completed a reset that extended its reinvestment end date from 20 July 2028 to 20 July 2030. The reset also reduced its WACC by around 74 bps, more than offsetting the decline in collateral WAS of roughly 63 bps.

Yesterday saw active trading in CLO equity. Blackstone, RBC BlueBay, Alcentra, and PGIM See Equity Tranches Stand Out in BWICs

BSP 2022-27A SUB traded and covered above par in yesterday’s BWIC (source: SCI). The deal was originally issued on 3 August 2022, and completed a highly accretive upsized reset in August 2024, extending its reinvestment end date from 20 July 2027 to 20 October 2029, with a call date of 20 October 2026.

A majority stake of GNRT 2024-16A SUB traded yesterday, covering at...

Yesterday saw a relatively long list of CLO equity tranches on BWIC. Among them, SIXST 2021-17X SUB stood out, ranking in the top quartile of its 2021-vintage peers.

Among the recently liquidated deals, those managed by CIFC and Carlyle—such as CIFC 2013-1A SUB, CIFC 2015-1A SUB, and CGMS 2013-1A SUB—stood out with IRRs ranging from 12.8% to 15.2%.

Among the top performers are Oak Hill Advisors, UBS AM, and Palmer Square Capital Management.

This week saw two majority equity blocks on BWIC: GNRT 2022-10A SUB with $31 million notional and ELM17 2022-4A SUB with $35 million notional.

The table in this article summarises the findings on equity IRRs for both reset and non-reset CLO equity tranches. Reset tranches have materially outperformed their non-reset counterparts. Generally, stronger-performing deals are more likely to undergo a reset. Underperforming deals often face challenges in resetting due to the substantial equity capital required, and equity investors may be reluctant to commit further capital to weaker-performing transactions. That said, exceptions do exist.

EU CLO equity has outperformed US CLO equity, based on BWIC colour from a sample of approximately 446 equity tranches traded since July 2024 (source: SCI). This trend is also consistent with findings from 2.0 CLO deals that have been fully liquidated to date, according to CLO Research.

The table below summarises the performance of US CLO deals that have been redeemed year-to-date.

This analysis examines a sample of 1,456 deals currently within their reinvestment periods.

Since January 2020, OHA has generated impressive, above-average inception-to-date total return alpha, driven by its consistent focus on minimising portfolio losses. This approach relies on rigorous, ongoing credit research and the regular application of that analysis to portfolio re-optimisation. The manager’s investment strategy is built on the belief that close collaboration across industry teams and integrated access to all asset classes within leveraged finance provide a robust foundation for research and portfolio construction.